Indicted Stimwave CEO Hit With $41M Civil Suit From SEC
The U.S. Securities and Exchange Commission on Tuesday accused the former CEO of bankrupt medical device maker Stimwave Technologies of defrauding investors out of roughly $41 million, filing a civil suit...To view the full article, register now.
Already a subscriber? Click here to view full article